Update of the JPIAMR Strategic Research and Innovation Agenda 2018
The JPIAMR recognises that innovation is critically important in the field of AMR, as there is a strong need of new therapeutics, diagnostics, and innovative infection prevention and intervention measures. The JPIAMR is therefore currently refreshing its JPIAMR Strategic Research Agenda (SRA) to take account of recent research findings and to extend the JPIAMR SRA into a Strategic Research and Innovation Agenda (SRIA).
The research objectives and research priorities of the JPIAMR SRIA are now open for public consultation. We welcome feedback on the research topics from the AMR community from the 9th of July to the 15th of September (12.00 CET).
For more information and instructions for providing feedback, please click here.
AMR, Antibioticresistance, antibotics, global, JPIAMR, open consultation, Research Agenda, SRIA